USP47 Antibodies

Santa Cruz Biotechnology provides a broad selection of USP47 monoclonal antibodies for research focused on understanding USP47 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USP47, or Ubiquitin Specific Peptidase 47, is a deubiquitinating enzyme that plays a critical role in regulating protein stability and cellular signaling pathways. By removing ubiquitin moieties from target proteins, USP47 influences various cellular processes, including cell cycle regulation and apoptosis. Research has shown that USP47 maintains cellular homeostasis and has potential implications in cancer and other diseases. Understanding USP47's molecular mechanisms and regulatory pathways can provide valuable insights into disease development and potential therapeutic strategies. Investigating USP47's role in different cellular contexts can reveal new perspectives on protein degradation pathways and their impact on cell function. Advanced research techniques using USP47 monoclonal antibodies enable precise detection and analysis of USP47 expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of USP47's biological significance and therapeutic potential.